悪性胸膜中皮腫:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Malignant Pleural Mesothelioma Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Malignant Pleural Mesothelioma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Malignant Pleural Mesothelioma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Malignant Pleural Mesothelioma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Malignant Pleural Mesothelioma 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Malignant Pleural Mesothelioma Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Malignant Pleural Mesothelioma 32
Dec 20, 2013: MolMed expands in Russia the Phase II trial of NGR-hTNF for the first line maintenance treatment of pleural mesothelioma 32
Oct 28, 2013: Polaris Group Announces Positive Results for Phase 2 Study of ADI-PEG 20 in Malignant Pleural Mesothelioma 32
Sep 10, 2013: Verastem Initiates COMMAND: A Registration-Directed Trial of Defactinib in Patients with Mesothelioma 33
Aug 27, 2013: Oncolytic Virus Specialist Virttu Biologics Confirms Treatment of First Cohort of Patients in Phase I/II SEPREHVIR Study in Mesothelioma 34
Mar 07, 2013: Oxford BioMedica Announces Initiation of Phase II Collaborative Study For TroVax In Malignant Pleural Mesothelioma 34
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Verastem, Inc. 38
Clinical Trial Overview of Verastem, Inc. 38
MolMed S.p.A. 39
Clinical Trial Overview of MolMed S.p.A. 39
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
Virttu Biologics Limited 41
Clinical Trial Overview of Virttu Biologics Limited 41
Polaris Group 42
Clinical Trial Overview of Polaris Group 42
Boehringer Ingelheim GmbH 43
Clinical Trial Overview of Boehringer Ingelheim GmbH 43
AstraZeneca PLC 44
Clinical Trial Overview of AstraZeneca PLC 44
Aduro BioTech, Inc. 45
Clinical Trial Overview of Aduro BioTech, Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
National Cancer Institute 46
Clinical Trial Overview of National Cancer Institute 46
Memorial Sloan Kettering Cancer Center 48
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 48
European Organization for Research and Treatment of Cancer 49
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 49
Istituto Clinico Humanitas 50
Clinical Trial Overview of Istituto Clinico Humanitas 50
The University of Texas M. D. Anderson Cancer Center 51
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 51
Columbia University 52
Clinical Trial Overview of Columbia University 52
Abramson Cancer Center 53
Clinical Trial Overview of Abramson Cancer Center 53
Hyogo College Of Medicine 54
Clinical Trial Overview of Hyogo College Of Medicine 54
University Health Network 55
Clinical Trial Overview of University Health Network 55
Five Key Clinical Profiles 56
Appendix 142
Abbreviations 142
Definitions 142
Research Methodology 143
Secondary Research 143
About GlobalData 144
Contact Us 144
Disclaimer 144
Source 145


【レポート販売概要】

■ タイトル:悪性胸膜中皮腫:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Malignant Pleural Mesothelioma Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2072CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。